Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 354

1.

A Retrospective Review: Patient-Reported Preoperative Prescription Opioid, Sedative, or Antidepressant Use is Associated with Worse Outcomes in Colorectal Surgery.

Gan T, Jackson NA, Castle JT, Davenport DL, Oyler DR, Ebbitt LM, Evers BM, Bhakta AS.

Dis Colon Rectum. 2020 Mar 31. doi: 10.1097/DCR.0000000000001655. [Epub ahead of print]

PMID:
32243351
2.

Polymicrobial infection confined to Ahmed glaucoma shunt.

Lee JC, Evers BM, Cavuoti D, Hogan RN, Kooner KS.

Am J Ophthalmol Case Rep. 2020 Jan 16;18:100596. doi: 10.1016/j.ajoc.2020.100596. eCollection 2020 Jun.

3.

Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with Ubiad1 deficiency.

Jo Y, Kim SS, Garland K, Fuentes I, DiCarlo LM, Ellis JL, Fu X, Booth SL, Evers BM, DeBose-Boyd RA.

Elife. 2020 Mar 2;9. pii: e54841. doi: 10.7554/eLife.54841.

4.

Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy.

Guo S, Vieweger M, Zhang K, Yin H, Wang H, Li X, Li S, Hu S, Sparreboom A, Evers BM, Dong Y, Chiu W, Guo P.

Nat Commun. 2020 Feb 20;11(1):972. doi: 10.1038/s41467-020-14780-5.

5.

Nonadherence to Standard of Care for Locally Advanced Colon Cancer as a Contributory Factor for High Mortality Rates in Kentucky.

Chow Z, Gan T, Chen Q, Huang B, Schoenberg N, Dignan M, Evers BM, Bhakta AS.

J Am Coll Surg. 2020 Apr;230(4):428-439. doi: 10.1016/j.jamcollsurg.2019.12.041. Epub 2020 Feb 13.

PMID:
32062006
6.

Transcriptional profiling identifies caspase-1 as a T cell-intrinsic regulator of Th17 differentiation.

Gao Y, Deason K, Jain A, Irizarry-Caro RA, Dozmorov I, Coughlin LA, Rauch I, Evers BM, Koh AY, Wakeland EK, Pasare C.

J Exp Med. 2020 Apr 6;217(4). pii: e20190476. doi: 10.1084/jem.20190476.

PMID:
31967646
7.

SIRT2 Contributes to the Regulation of Intestinal Cell Proliferation and Differentiation.

Li C, Zhou Y, Rychahou P, Weiss HL, Lee EY, Perry CL, Barrett TA, Wang Q, Evers BM.

Cell Mol Gastroenterol Hepatol. 2020 Jan 16. pii: S2352-345X(20)30004-7. doi: 10.1016/j.jcmgh.2020.01.004. [Epub ahead of print]

8.

The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion.

Wang J, Yu Q, Qiu Z, Dai T, Wang S, Yang X, Evers BM, Wu Y.

Aging (Albany NY). 2020 Jan 5;12(1):397-415. doi: 10.18632/aging.102630. Epub 2020 Jan 5.

9.

An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt Inhibitors.

Zhang W, Sviripa VM, Kril LM, Yu T, Xie Y, Hubbard WB, Sullivan PG, Chen X, Zhan CG, Yang-Hartwich Y, Evers BM, Spear BT, Gedaly R, Watt DS, Liu C.

J Med Chem. 2019 Dec 26;62(24):11348-11358. doi: 10.1021/acs.jmedchem.9b01685. Epub 2019 Dec 16.

PMID:
31774672
10.

Biliary tract large cell neuroendocrine carcinoma: current evidence.

Raiker R, Chauhan A, Hasanein H, Burkeen G, Horn M, Veedu J, Vela C, Arnold S, Kolesar J, Anthony L, Evers BM, Cavnar M.

Orphanet J Rare Dis. 2019 Nov 21;14(1):266. doi: 10.1186/s13023-019-1230-2. Review.

11.

Comment on "Training the Surgeon-Scientist in Today's Healthcare Environment".

DeCoster RC, Bautista RF, Evers BM.

Ann Surg. 2019 Dec;270(6):e124-e125. doi: 10.1097/SLA.0000000000003302. No abstract available.

PMID:
31726641
12.

Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation.

Sinner HF, Johnson J, Rychahou PG, Watt DS, Zaytseva YY, Liu C, Evers BM.

PLoS One. 2019 Oct 24;14(10):e0224253. doi: 10.1371/journal.pone.0224253. eCollection 2019.

13.

Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells.

Kim JT, Li C, Weiss HL, Zhou Y, Liu C, Wang Q, Evers BM.

Cells. 2019 Sep 19;8(9). pii: E1106. doi: 10.3390/cells8091106.

14.

Foreign-Body Granulomata Caused by Injected Permanent Filler Masquerading as Cutaneous Sarcoidosis.

Scofield-Kaplan SM, Patel SY, Mueller A, Ford WC, Evers BM, Hogan RN, Mancini R.

Ophthalmic Plast Reconstr Surg. 2019 May/Jun;35(3):e82-e84. doi: 10.1097/IOP.0000000000001385.

PMID:
30921058
15.

Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling.

Rock S, Li X, Song J, Townsend CM Jr, Weiss HL, Rychahou P, Gao T, Li J, Evers BM.

PLoS One. 2019 Mar 27;14(3):e0211134. doi: 10.1371/journal.pone.0211134. eCollection 2019.

16.

S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2.

Liu L, Qi L, Knifley T, Piecoro DW, Rychahou P, Liu J, Mitov MI, Martin J, Wang C, Wu J, Weiss HL, Butterfield DA, Evers BM, O'Connor KL, Chen M.

J Biol Chem. 2019 May 3;294(18):7516-7527. doi: 10.1074/jbc.RA118.004365. Epub 2019 Mar 18.

PMID:
30885944
17.

Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.

Johnson J, Rychahou P, Sviripa VM, Weiss HL, Liu C, Watt DS, Evers BM.

PLoS One. 2019 Mar 15;14(3):e0209392. doi: 10.1371/journal.pone.0209392. eCollection 2019.

18.

Impact of the Affordable Care Act on Colorectal Cancer Screening, Incidence, and Survival in Kentucky.

Gan T, Sinner HF, Walling SC, Chen Q, Huang B, Tucker TC, Patel JA, Evers BM, Bhakta AS.

J Am Coll Surg. 2019 Apr;228(4):342-353.e1. doi: 10.1016/j.jamcollsurg.2018.12.035. Epub 2019 Feb 22.

19.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R.

Acta Neuropathol. 2019 Jun;137(6):879-899. doi: 10.1007/s00401-019-01962-9. Epub 2019 Feb 9.

PMID:
30739198
20.

Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary

Chauhan A, Farooqui Z, Silva SR, Murray A, Hodges KB, Yu Q, Myint ZW, Raajesekar AK, Weiss H, Arnold S, Evers BM, Anthony L.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):113-116.

21.

Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer.

Liu J, Duan Z, Guo W, Zeng L, Wu Y, Chen Y, Tai F, Wang Y, Lin Y, Zhang Q, He Y, Deng J, Stewart RL, Wang C, Lin PC, Ghaffari S, Evers BM, Liu S, Zhou MM, Zhou BP, Shi J.

Nat Commun. 2018 Dec 5;9(1):5200. doi: 10.1038/s41467-018-07258-y.

22.

Unusual Location for a Periorbital Dermoid Cyst.

Scofield-Kaplan SM, Sobti D, Evers BM, Hogan RN, Mancini R.

Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):e208-e209. doi: 10.1097/IOP.0000000000001255.

PMID:
30418405
23.

Modulation of Mutant KrasG12D -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function.

Zhou X, Padanad MS, Evers BM, Smith B, Novaresi N, Suresh S, Richardson JA, Stein E, Zhu J, Hammer RE, O'Donnell KA.

Mol Cancer Res. 2019 Feb;17(2):594-603. doi: 10.1158/1541-7786.MCR-18-0739. Epub 2018 Nov 8.

24.

De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.

Jafari N, Drury J, Morris AJ, Onono FO, Stevens PD, Gao T, Liu J, Wang C, Lee EY, Weiss HL, Evers BM, Zaytseva YY.

Mol Cancer Res. 2019 Jan;17(1):140-152. doi: 10.1158/1541-7786.MCR-18-0199. Epub 2018 Aug 28.

25.

Development of murine bariatric surgery models: lessons learned.

Frohman HA, Rychahou PG, Li J, Gan T, Evers BM.

J Surg Res. 2018 Sep;229:302-310. doi: 10.1016/j.jss.2018.04.022. Epub 2018 May 10.

26.

Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary.

Chauhan A, Farooqui Z, Murray LA, Weiss HL, War Myint Z, Raajasekar AKA, Evers BM, Arnold S, Anthony L.

J Oncol. 2018 May 7;2018:3519247. doi: 10.1155/2018/3519247. eCollection 2018.

27.

FFAR4 Is Involved in Regulation of Neurotensin Release From Neuroendocrine Cells and Male C57BL/6 Mice.

Li J, Song J, Li X, Rock SB, Sinner HF, Weiss HL, Weiss T, Townsend CM Jr, Gao T, Evers BM.

Endocrinology. 2018 Aug 1;159(8):2939-2952. doi: 10.1210/en.2018-00284.

28.

Remote acoustic sensing as a safety mechanism during exposure of metal implants to alternating magnetic fields.

Cheng B, Chatzinoff Y, Szczepanski D, Bing C, Shaikh S, Wyman O, Perry CE, Richardson JA, Burns DK, Evers BM, Greenberg DE, Chopra R.

PLoS One. 2018 May 10;13(5):e0197380. doi: 10.1371/journal.pone.0197380. eCollection 2018.

29.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

30.

Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.

Wang Q, Zhou Y, Rychahou P, Harris JW, Zaytseva YY, Liu J, Wang C, Weiss HL, Liu C, Lee EY, Evers BM.

Cancer Res. 2018 Jun 15;78(12):3163-3175. doi: 10.1158/0008-5472.CAN-17-3107. Epub 2018 Apr 17.

31.

Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.

Wen YA, Xiong X, Zaytseva YY, Napier DL, Vallee E, Li AT, Wang C, Weiss HL, Evers BM, Gao T.

Cell Death Dis. 2018 Feb 15;9(3):265. doi: 10.1038/s41419-018-0330-6.

32.

Neurotensin Receptor 3/Sortilin Contributes to Tumorigenesis of Neuroendocrine Tumors Through Augmentation of Cell Adhesion and Migration.

Kim JT, Napier DL, Weiss HL, Lee EY, Townsend CM Jr, Evers BM.

Neoplasia. 2018 Feb;20(2):175-181. doi: 10.1016/j.neo.2017.11.012. Epub 2017 Dec 19.

33.

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1.

Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, Liu S, Wang C, Yang HS, Zhou BP, Evers BM, She QB.

Nat Commun. 2017 Dec 20;8(1):2207. doi: 10.1038/s41467-017-02243-3.

34.

Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.

Pi F, Binzel DW, Lee TJ, Li Z, Sun M, Rychahou P, Li H, Haque F, Wang S, Croce CM, Guo B, Evers BM, Guo P.

Nat Nanotechnol. 2018 Jan;13(1):82-89. doi: 10.1038/s41565-017-0012-z. Epub 2017 Dec 11.

35.

Stabilization of the transcription factors slug and twist by the deubiquitinase dub3 is a key requirement for tumor metastasis.

Lin Y, Wang Y, Shi Q, Yu Q, Liu C, Feng J, Deng J, Evers BM, Zhou BP, Wu Y.

Oncotarget. 2017 Aug 24;8(43):75127-75140. doi: 10.18632/oncotarget.20561. eCollection 2017 Sep 26.

36.

Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency.

Evers BM, Rodriguez-Navas C, Tesla RJ, Prange-Kiel J, Wasser CR, Yoo KS, McDonald J, Cenik B, Ravenscroft TA, Plattner F, Rademakers R, Yu G, White CL 3rd, Herz J.

Cell Rep. 2017 Sep 12;20(11):2565-2574. doi: 10.1016/j.celrep.2017.08.056.

37.

Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.

Kim JT, Weiss HL, Evers BM.

Int J Oncol. 2017 Jun;50(6):2200-2206. doi: 10.3892/ijo.2017.3990. Epub 2017 May 9.

38.

Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines.

Mitov MI, Harris JW, Alstott MC, Zaytseva YY, Evers BM, Butterfield DA.

Exp Cell Res. 2017 May 15;354(2):112-121. doi: 10.1016/j.yexcr.2017.03.046. Epub 2017 Mar 22.

39.

Fluorinated N,N'-Diarylureas As Novel Therapeutic Agents Against Cancer Stem Cells.

Kenlan DE, Rychahou P, Sviripa VM, Weiss HL, Liu C, Watt DS, Evers BM.

Mol Cancer Ther. 2017 May;16(5):831-837. doi: 10.1158/1535-7163.MCT-15-0634. Epub 2017 Mar 3.

40.

Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.

Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, Singh P, Chi YI, Wang C, Dong C, Li W, Tao M, Napier D, Shi Q, Deng J, Evers BM, Zhou BP.

Nat Commun. 2017 Feb 15;8:14228. doi: 10.1038/ncomms14228.

41.

Colorectal cancer: A new innate immune sensor - functions from inside the colonic epithelium.

Gao T, Evers BM.

Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):199-200. doi: 10.1038/nrgastro.2017.10. Epub 2017 Feb 15. No abstract available.

PMID:
28196986
42.

Ketogenesis contributes to intestinal cell differentiation.

Wang Q, Zhou Y, Rychahou P, Fan TW, Lane AN, Weiss HL, Evers BM.

Cell Death Differ. 2017 Mar;24(3):458-468. doi: 10.1038/cdd.2016.142. Epub 2016 Dec 9.

43.

KLF4 deletion alters gastric cell lineage and induces MUC2 expression.

Yu T, Chen X, Lin T, Liu J, Li M, Zhang W, Xu X, Zhao W, Liu M, Napier DL, Wang C, Evers BM, Liu C.

Cell Death Dis. 2016 Jun 9;7(6):e2255. doi: 10.1038/cddis.2016.158.

44.

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.

Upreti M, Jyoti A, Johnson SE, Swindell EP, Napier D, Sethi P, Chan R, Feddock JM, Weiss HL, O'Halloran TV, Evers BM.

Oncotarget. 2016 Jul 5;7(27):41559-41574. doi: 10.18632/oncotarget.9490.

45.

An obligatory role for neurotensin in high-fat-diet-induced obesity.

Li J, Song J, Zaytseva YY, Liu Y, Rychahou P, Jiang K, Starr ME, Kim JT, Harris JW, Yiannikouris FB, Katz WS, Nilsson PM, Orho-Melander M, Chen J, Zhu H, Fahrenholz T, Higashi RM, Gao T, Morris AJ, Cassis LA, Fan TW, Weiss HL, Dobner PR, Melander O, Jia J, Evers BM.

Nature. 2016 May 19;533(7603):411-5. doi: 10.1038/nature17662. Epub 2016 May 11.

46.

Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma.

Vilchez V, Turcios L, Zaytseva Y, Stewart R, Lee EY, Maynard E, Shah MB, Daily MF, Tzeng CW, Davenport D, Castellanos AL, Krohmer S, Hosein PJ, Evers BM, Gedaly R.

Am J Surg. 2016 Aug;212(2):238-45. doi: 10.1016/j.amjsurg.2015.12.019. Epub 2016 Feb 27.

PMID:
27033253
47.

PI(4)P Promotes Phosphorylation and Conformational Change of Smoothened through Interaction with Its C-terminal Tail.

Jiang K, Liu Y, Fan J, Zhang J, Li XA, Evers BM, Zhu H, Jia J.

PLoS Biol. 2016 Feb 10;14(2):e1002375. doi: 10.1371/journal.pbio.1002375. eCollection 2016 Feb.

48.

Controllable self-assembly of RNA dendrimers.

Sharma A, Haque F, Pi F, Shlyakhtenko LS, Evers BM, Guo P.

Nanomedicine. 2016 Apr;12(3):835-844. doi: 10.1016/j.nano.2015.11.008. Epub 2015 Dec 2.

49.

Activation of AMPK Stimulates Neurotensin Secretion in Neuroendocrine Cells.

Li J, Song J, Weiss HL, Weiss T, Townsend CM Jr, Evers BM.

Mol Endocrinol. 2016 Jan;30(1):26-36. doi: 10.1210/me.2015-1094. Epub 2015 Nov 3.

50.

Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.

Kim JT, Li J, Song J, Lee EY, Weiss HL, Townsend CM Jr, Evers BM.

Oncotarget. 2015 Sep 29;6(29):26960-70. doi: 10.18632/oncotarget.4745.

Supplemental Content

Loading ...
Support Center